Association of cardio-ankle vascular index and future major adverse cardiovascular events in older adults living with HIV

References

• Asmar, R. (2017). Principles and usefulness of the cardio-ankle vascular index (CAVI): a new global arterial stiffness index. European Heart Journal Supplements, 19(Suppl. B), B4–10. https://doi.org/10.1159/000448464
   Google Scholar
• Aurpibul, L., Srithanaviboonchai, K., Rerkasem, K., Tangmunkongvorakul, A., Sitthi, W., & Musumari, P. M. (2019). Prevalence of subclinical atherosclerosis and risk of atherosclerotic cardiovascular disease in older adults living with HIV. AIDS Research and Human Retroviruses, 35(11–12), 1136–1142. https://doi.org/10.1089/AID.2019.0023
   PubMed Web of Science ®Google Scholar
• Bijker, R., Jiamsakul, A., Uy, E., Kumarasamy, N., Ditango, R., Chaiwarith, R., Wong, W. W., Avihingsanon, A., Sun, L. P., Yunihastuti, E., Pujari, S., Do, C. D., Merati, T. P., Kantipong, P., Nguyen, K. V., Kamarulzaman, A., Zhang, F., Lee, M. P., Choi, J. Y., & Kiertiburanakul, S. (2019). Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD). HIV Medicine, 20(3), 183–191. https://doi.org/10.1111/hiv.12687
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. (2020, May). HIV surveillance report, 2018 (updated). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
   Google Scholar
• Chung, S. L., Yang, C. C., Chen, C. C., Hsu, Y. C., & Lei, M. H. (2015). Coronary artery calcium score compared with cardio-ankle vascular index in the prediction of cardiovascular events in asymptomatic patients with type 2 diabetes. Journal of Atherosclerosis and Thrombosis, 22(12), 1255–1265. https://doi.org/10.5551/jat.29926
   PubMed Web of Science ®Google Scholar
• Covic, A., & Siriopol, D. (2015). Pulse wave velocity ratio: The new “gold standard” for measuring arterial stiffness. American Heart Association, 65(2), 289–290. https://doi.org/10.1161/HYPERTENSIONAHA.114.04678
   Google Scholar
• Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group, Smith, C., Sabin, C. A., Lundgren, J. D., Thiebaut, R., Weber, R., Law, M., Monforte, A., Kirk, O., Friis-Moller, N., Phillips, A., Reiss, P., El Sadr, W., Pradier, C., & Worm, S. W. (2010). Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study. AIDS, 24(10), 1537–1548. https://doi.org/10.1097/QAD.0b013e32833a0918
   PubMedGoogle Scholar
• Edwards-Jackson, N., Kerr, S., Tieu, H., Ananworanich, J., Hammer, S., Ruxrungtham, K., Phanuphak, P., Avihingsanon, A., & HIV-NAT 006 Study Team. (2011). Cardiovascular risk assessment in persons with HIV infection in the developing world: Comparing three risk equations in a cohort of HIV-infected Thais. HIV Medicine, 12(8), 510–515. https://doi.org/10.1111/j.1468-1293.2011.00916.x
   PubMedGoogle Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001). Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 285(19), 2486–2497. https://doi.org/10.1001/jama.285.19.2486
   PubMed Web of Science ®Google Scholar
• Falster, K., Choi, J. Y., Donovan, B., Duncombe, C., Mulhall, B., Sowden, D., Zhou, J., Law, M. G., Australian HIV Observational Database, & TREAT Asia HIV Observational Database. (2009). AIDS-related and non-AIDS-related mortality in the Asia Pacific region in the era of combination antiretroviral treatment. AIDS, 23(17), 2323–2336. https://doi.org/10.1097/QAD.0b013e328331910c
   PubMed Web of Science ®Google Scholar
• Greenland, S. (2014). Wiley StatsRef. Statistics reference online: Confounder summary score. John Wiley and Sons. https://onlinelibrary.wiley.com/doi/abs/10.1002/9781118445112.stat05133
   Google Scholar
• Grome, H. N., Barnett, L., Hagar, C. C., Harrison, D. G., Kalams, S. A., & Koethe, J. R. (2017). Association of T cell and macrophage activation with arterial vascular health in HIV. AIDS Research and Human Retroviruses, 33(2), 181–186. https://doi.org/10.1089/AID.2016.0113
   PubMedGoogle Scholar
• Han, N., Wright, S. T., O’Connor, C. C., Hoy, J., Ponnampalavanar, S., Grotowski, M., Zhao, H. X., Kamarulzaman, A., Australian HIV Observational Database (AHOD), & TREAT Asia HIV Observational Database (TAHOD). (2015). HIV and aging: Insights from the Asia Pacific HIV Observational Database (APHOD). HIV Medicine, 16(3), 152–160. https://doi.org/10.1111/hiv.12188
   PubMed Web of Science ®Google Scholar
• Hu, H., Cui, H., Han, W., Ye, L., Qiu, W., Yang, H., Zhang, C., Guo, X., & Mao, G. (2013). A cutoff point for arterial stiffness using the cardio-ankle vascular index based on carotid arteriosclerosis. Hypertension Research, 36(4), 334–341. https://doi.org/10.1038/hr.2012.192
   PubMedGoogle Scholar
• Karim, R., Mack, W. J., Kono, N., Tien, P. C., Anastos, K., Lazar, J., Young, M., Desai, S., Golub, E. T., Kaplan, R. C., Hodis, H. N., & Kovacs, A. (2014). T-cell activation, both pre-and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHS. Journal of Acquired Immune Deficiency Syndromes, 67(3), 349. https://doi.org/10.1097/QAI.0000000000000311
   PubMedGoogle Scholar
• Kato, A., Takita, T., Furuhashi, M., Maruyama, Y., Miyajima, H., & Kumagai, H. (2012). Brachial-ankle pulse wave velocity and the cardio-ankle vascular index as a predictor of cardiovascular outcomes in patients on regular hemodialysis: baPWV and CAVI as a predictor of outcomes. Therapeutic Apheresis and Dialysis, 16(3), 232–241. https://doi.org/10.1111/j.1744-9987.2012.01058.x
   PubMedGoogle Scholar
• Krikke, M., Hoogeveen, R. C., Hoepelman, A. I. M., Visseren, F. L. J., & Arends, J. E. (2016). Cardiovascular risk prediction in HIV-infected patients: Comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models. HIV Medicine, 17(4), 289–297. https://doi.org/10.1111/hiv.12300
   PubMedGoogle Scholar
• Kubota, Y., Maebuchi, D., Takei, M., Inui, Y., Sudo, Y., Ikegami, Y., Jun, F., Sakamoto, M., & Momiyama, Y. (2011). Cardio-ankle vascular index is a predictor of cardiovascular events. Artery Research, 5(3), 91–96. https://doi.org/10.1016/j.artres.2011.03.005
   Google Scholar
• Kusunose, K., Sato, M., Yamada, H., Saijo, Y., Bando, M., Hirata, Y., Nishio, S., Hayashi, S., & Sata, M. (2016). Prognostic implications of non-invasive vascular function tests in high-risk atherosclerosis patients. Circulation Journal, 80(4), 1034–1040. https://doi.org/10.1253/circj.CJ-15-1356
   PubMedGoogle Scholar
• Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. L., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., Coresh, J., & CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). (2019). A new equation to estimate glomerular filtration rate. Annals of Internal Medicine, 150(9), 604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
   Google Scholar
• Lichtenstein, K. A., Armon, C., Buchacz, K., Chmiel, J. S., Buckner, K., Tedaldi, E. M., Wood, K., Holmberg, S. D., Brooks, J. T., & HIV Outpatient Study (HOPS) Investigators. (2010). Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clinical Infectious Diseases, 51(4), 435–447. https://doi.org/10.1086/655144
   PubMed Web of Science ®Google Scholar
• Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., Galderisi, M., Grobbee, D. E., Jaarsma, T., Kirchhof, P., Kjeldsen, S. E., Laurent, S., Manolis, A. J., Nilsson, P. M., Ruilope, L. M., Zannad, F., & Task Force Members. (2013). 2013 ESH/ESC guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension, 31(7), 1281–1357. https://doi.org/10.1097/01.hjh.0000431740.32696.cc
   PubMed Web of Science ®Google Scholar
• Misra, A., Vikram, N. K., Gupta, R., Pandey, R. M., Wasir, J. S., & Gupta, V. P. (2006). Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. International Journal of Obesity, 30(1), 106–111. https://doi.org/10.1038/sj.ijo.0803111
   Web of Science ®Google Scholar
• Miyashita, Y., Saiki, A., Endo, K., Ban, N., Yamaguchi, T., Kawana, H., Nagayama, D., Ohira, M., Oyama, T., & Shirai, K. (2009). Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on cardio-ankle vascular index (CAVI) in type 2 diabetic patients with hypertension. Journal of Atherosclerosis and Thrombosis, 16(5), 621–626. https://doi.org/10.5551/jat.497
   PubMedGoogle Scholar
• Miyoshi, T., & Ito, H. (2016). Assessment of arterial stiffness using the cardio-ankle vascular index. Pulse, 4(1), 11–23. https://doi.org/10.1159/000445214
   Google Scholar
• Nagayama, D., Endo, K., Ohira, M., Yamaguchi, T., Ban, N., Kawana, H., Nagumo, A., Saiki, A., Oyama, T., Miyashita, Y., & Shirai, K. (2013). Effects of body weight reduction on cardio-ankle vascular index (CAVI). Obesity Research and Clinical Practice, 7(2), e139–e145. https://doi.org/10.1016/j.orcp.2011.08.154
   PubMedGoogle Scholar
• Nakamura, K., Tomaru, T., Yamamura, S., Miyashita, Y., Shirai, K., & Noike, H. (2008). Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circulation Journal, 72(4), 598–604. https://doi.org/10.1253/circj.72.598
   PubMed Web of Science ®Google Scholar
• Namekata, T., Suzuki, K., Ishizuka, N., & Shirai, K. (2011). Establishing baseline criteria of cardio-ankle vascular index as a new indicator of arteriosclerosis: A cross-sectional study. BMC Cardiovascular Disorders, 11(1), 1–10. https://doi.org/10.1186/1471-2261-11-51
   PubMedGoogle Scholar
• Ohira, M., Yamaguchi, T., Saiki, A., Ban, N., Kawana, H., Nagumo, A., Murano, T., Shirai, K., & Tatsuno, I. (2014). Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin. Diabetes Metabolic Syndrome and Obesity Targets and Therapy, 7, 313–319. https://doi.org/10.2147/DMSO.S65275
   PubMedGoogle Scholar
• Park, S. Y., Chin, S. O., Rhee, S. Y., Oh, S., Woo, J. T., Kim, S. W., & Chon, S. (2018). Cardio-ankle vascular index as a surrogate marker of early atherosclerotic cardiovascular disease in Koreans with type 2 diabetes mellitus. Diabetes and Metabolism Journal, 42(4), 285–295. https://doi.org/10.4093/dmj.2017.0080
   PubMed Web of Science ®Google Scholar
• Pattanaprichakul, S., Jongjirasiri, S., Yamwong, S., Laothammatas, J., & Sritara, P. (2007). RAMA-EGAT risk score for predicting coronary artery disease evaluated by 64-slice CT angiography. Asean Heart Journal, 15(1), 18–22.
   Google Scholar
• Rothman, K. J. (2012). Epidemiology: Overfitting of regression models and summary confounder scores. Oxford University Press.
   Google Scholar
• Sato, Y., Nagayama, D., Saiki, A., Watanabe, R., Watanabe, Y., Imamura, H., Yamaguchi, T., Ban, N., Kawana, H., Nagumo, A., Ohira, M., Endo, K., Kurosu, T., Tomaru, T., Shirai, K., & Tatsuno, I. (2016). Cardio-ankle vascular index is independently associated with future cardiovascular events in outpatients with metabolic disorders. Journal of Atherosclerosis and Thrombosis, 23(5), 596–605. https://doi.org/10.5551/jat.31385
   PubMed Web of Science ®Google Scholar
• Satoh-Asahara, N., Kotani, K., Yamakage, H., Yamada, T., Araki, R., Okajima, T., Adachi, M., Oishi, M., Shimatsu, A., & Japan Obesity and Metabolic Syndrome Study (JOMS) Group. (2015). Cardio-ankle vascular index predicts for the incidence of cardiovascular events in obese patients: A multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study: JOMS). Atherosclerosis, 242(2), 461–468. https://doi.org/10.1016/j.atherosclerosis.2015.08.003
   PubMed Web of Science ®Google Scholar
• Shah, A. S. V., Stelzle, D., Lee, K. K., Beck, E. J., Alam, S., Clifford, S., Longenecker, C. T., Strachan, F., Bagchi, S., Whiteley, W., Rajagopalan, S., Kottilil, S., Nair, H., Newby, D. E., McAllister, D. A., & Mills, N. L. (2018). Global burden of atherosclerotic cardiovascular disease in people living with HIV: Systematic review and meta-analysis. Circulation, 138(11), 1100–1112. https://doi.org/10.1161/CIRCULATIONAHA.117.033369
   PubMed Web of Science ®Google Scholar
• Sritara, P., Cheepudomwit, S., Chapman, N., Woodward, M., Kositchaiwat, C., Tunlayadechanont, S., Sura, T., Hengprasith, B., Tanphaichitr, V., Lochaya, S., Neal, B., Tanomsup, S., Yipintsoi, T., & Electricity Generating Authority of Thailand. (2003). Twelve-year changes in vascular risk factors and their associations with mortality in a cohort of 3499 Thais: The Electricity Generating Authority of Thailand Study. International Journal of Epidemiology, 32(3), 461–468. https://doi.org/10.1093/ije/dyg105
   PubMedGoogle Scholar
• Sun, C. K. (2013). Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness. Integrated Blood Pressure Control, 6, 27–38. https://doi.org/10.2147/IBPC.S34423
   PubMedGoogle Scholar
• Suppadungsuk, S., Yamwong, S., & Sungkanuparph, S. (2013). Risk of cardiovascular events predicted by the Rama-EGAT score among HIV-infected patients in Thailand. The Southeast Asian Journal of Tropical Medicine and Public Health, 44(5), 818–824.
   PubMedGoogle Scholar
• Thitiwuthikiat, P., Imerbtham, T., Weeraphan, O., & Siriwittayawan, D. (2018). Improvement of cardio-ankle vascular index by arm-swing exercise in older adults. Songklanagarind Medical Journal, 36(1), 53–60. https://doi.org/10.31584/smj.2018.36.1.767
   Google Scholar
• Triant, V. A., Perez, J., Regan, S., Massaro, J. M., Meigs, J. B., Grinspoon, S. K., & D’Agostino, R. B. (2018). Cardiovascular risk prediction functions underestimate risk in HIV infection. Circulation, 137(21), 2203–2214. https://doi.org/10.1161/CIRCULATIONAHA.117.028975
   PubMed Web of Science ®Google Scholar
• Wohlfahrt, P., Cífková, R., Movsisyan, N., Kunzová, Š, Lešovský, J., Homolka, M., Soška, V., Dobšák, P., Lopez-Jimenez, F., & Sochor, O. (2017). Reference values of cardio-ankle vascular index in a random sample of a Caucasian population. Artery Research, 20(C), 65–66. https://doi.org/10.1097/HJH.0000000000001437
   Google Scholar
• Yingchoncharoen, T., Limpijankit, T., Jongjirasiri, S., Laothamatas, J., Yamwong, S., & Sritara, P. (2012). Arterial stiffness contributes to coronary artery disease risk prediction beyond the traditional risk score (RAMA-EGAT score). Heart Asia, 4(1), 77–82. https://doi.org/10.1136/heartasia-2011-010079
   PubMedGoogle Scholar
• Zanni, M. V., & Grinspoon, S. K. (2012). HIV-specific immune dysregulation and atherosclerosis. Current HIV/AIDS Reports, 9(3), 200–205. https://doi.org/10.1007/s11904-012-0123-y
   PubMedGoogle Scholar